{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Coronavirus",
      "Health care\u2013acquired infection",
      "Infection prevention",
      "Influenza",
      "Nosocomial infection",
      "Respiratory virus",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34752220",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.idc.2021.07.007",
      "S0891-5520(21)00068-4"
    ],
    "Journal": {
      "ISSN": "1557-9824",
      "JournalIssue": {
        "Volume": "35",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec"
        }
      },
      "Title": "Infectious disease clinics of North America",
      "ISOAbbreviation": "Infect Dis Clin North Am"
    },
    "ArticleTitle": "Health Care-Acquired Viral Respiratory Diseases.",
    "Pagination": {
      "StartPage": "1055",
      "EndPage": "1075",
      "MedlinePgn": "1055-1075"
    },
    "Abstract": {
      "AbstractText": [
        "Health care-acquired viral respiratory infections are common and cause increased patient morbidity and mortality. Although the threat of viral respiratory infection has been underscored by the coronavirus disease 2019 (COVID-19) pandemic, respiratory viruses have a significant impact in health care settings even under normal circumstances. Studies report decreased nosocomial transmission when aggressive infection control measures are implemented, with more success noted when using a multicomponent approach. Influenza vaccination of health care personnel furthers decrease rates of transmission; thus, mandatory vaccination is becoming more common. This article discusses the epidemiology, transmission, and control of health care-associated respiratory viral infections."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109, USA."
          }
        ],
        "LastName": "Petrie",
        "ForeName": "Joshua G",
        "Initials": "JG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, 1161 21st Avenue South, A-2200 MCN, Nashville, TN 37232, USA. Electronic address: tom.talbot@vumc.org."
          }
        ],
        "LastName": "Talbot",
        "ForeName": "Thomas R",
        "Initials": "TR"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K01 AI141579",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Infect Dis Clin North Am",
    "NlmUniqueID": "8804508",
    "ISSNLinking": "0891-5520"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Guideline Adherence"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Health Personnel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Infection Control"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccination"
    },
    {
      "QualifierName": [
        "classification",
        "pathogenicity"
      ],
      "DescriptorName": "Viruses"
    }
  ],
  "CoiStatement": "Disclosure J.G. Petrie and T.R. Talbot have no disclosures."
}